Back
Day Range
$55.05
$57.12
52-Week Range
$27.66
$75.33
Volume
1,024,037
50D / 200D Avg
$54.82
/
$42.62
Prev Close
$54.72
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10.5 | 0.4 |
| P/B | 3.0 | 2.9 |
| ROE % | -25.6 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -669.29M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-25.59%
ROIC-23.77%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.09
Current Ratio7.91
Interest Coverage0.00
Valuation
P/E Ratio
-10.50
P/B Ratio3.00
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -766.63M |
| ROE | -25.59% | ROA | -25.17% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -669.29M |
| ROIC | -23.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 7.91 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.50 | P/B Ratio | 3.00 |
| P/S Ratio | N/A | PEG Ratio | -0.17 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 8.05B | Enterprise Value | 8.11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -766.63M | -463.93M | -402.27M | -223.49M | -100.08M |
| EPS (Diluted) | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -923.68M | -569.55M | -468.04M | -232.26M | -103.67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.05B | 3.51B | 1.41B | 1.01B | 324.34M |
| Total Liabilities | 360.46M | 205.50M | 167.45M | 52.57M | 40.32M |
| Shareholders' Equity | 2.69B | 3.31B | 1.24B | 953.61M | 284.02M |
| Total Debt | 228.84M | 71.11M | 29.22M | 17.94M | 16.78M |
| Cash & Equivalents | 173.96M | 387.88M | 397.45M | 834.66M | 68.99M |
| Current Assets | 1.63B | 1.79B | 1.10B | 942.56M | 256.35M |
| Current Liabilities | 205.75M | 140.18M | 145.34M | 40.53M | 28.72M |